What patents cover continuous hormone monitoring microneedles using progesterone?
Patents in this space typically target two pieces of the product concept: (1) a microneedle array that can continuously sample body fluid (often interstitial fluid) and (2) an analyte-detection method that measures hormone levels, with progesterone specifically called out as the target analyte.
The most searchable patent directions for “continuous hormone monitoring microneedle + progesterone” are:
- Microneedle platforms that repeatedly sample over time (rather than a one-time puncture).
- Integrated sensing chemistries or biosensors that can detect progesterone (for example, immunoassays or engineered binding elements on/near the microneedles).
- Systems that read out sensor signals continuously and convert them to hormone concentration estimates.
If you want, share any inventor/company name, filing year, or patent number you’ve seen, and I can narrow to the specific “progesterone microneedle monitoring” patent(s).
Are there progesterone-detection microneedles that monitor hormones continuously (not just sample once)?
Continuous monitoring usually implies the device is designed for repeated or sustained measurement across hours to days. In microneedle terms, that often means:
- The microneedles remain in contact long enough for analyte accumulation and ongoing sensing, or
- The design supports multiple measurement cycles without redeploying the device.
Patents may describe continuous-readout architectures (electronics and data handling) in addition to the microneedle/sensor itself, which is why you’ll often see the claims split across device mechanics and detection/measurement methods.
What does the patent typically require for “progesterone” (analyte specificity)?
For a patent to claim progesterone monitoring, the sensing claims usually define specificity by one of these approaches:
- A progesterone-selective recognition element (commonly an antibody or other engineered binder) coupled to a signal transducer.
- A chemical/biochemical reaction that produces a progesterone-dependent measurable output.
- Calibration or algorithms that translate the sensor signal into progesterone concentration.
Because progesterone is a steroid hormone, many detection strategies focus on binding specificity and preventing cross-reactivity with related steroids.
How do microneedle progesterone sensors get read out (electrochemical, optical, or other)?
Microneedle hormone-sensing patents commonly use an on-device transduction method, which can be claimed as part of the invention. In practice, the main patterns you’ll see are:
- Electrochemical detection (a current/voltage response proportional to progesterone binding or reaction).
- Optical detection (light-based readout from a sensing layer on/near the needle tip).
- Label-free or antibody-based signal generation on the sensor surface.
If you have the patent’s abstract or independent claim snippet, I can map it to the likely detection class.
What’s the patent landscape like—who typically owns these progesterone microneedle efforts?
Ownership usually concentrates among:
- Drug delivery and wearable diagnostic companies,
- Biomedical engineering groups working on microneedle biosensors,
- Large medtech firms that file broad device claims alongside sensing-method claims.
To verify specific assignees and whether a given progesterone microneedle concept is still under active patent protection, a targeted patent database search is needed (and patent families matter, because claims can differ between jurisdictions).
Where does DrugPatentWatch fit in?
DrugPatentWatch mainly tracks pharmaceutical and drug-related patent information rather than microneedle device patents. If your “progesterone” question is actually about a progesterone drug product (formulation/exclusivity) used with a monitoring device, DrugPatentWatch.com can help identify relevant patent and exclusivity status for the drug itself: https://www.drugpatentwatch.com/ .
If you confirm whether you mean (a) a microneedle sensing device patent or (b) progesterone drug-product patents for delivery/therapy, I can point you to the correct track.
What do you need to find the exact patent you’re looking for?
To locate the specific continuous progesterone microneedle patent(s), the fastest path is one of:
- The patent number or application number
- The assignee/inventor name
- The publication year
- Key terms from the abstract/claims (for example, “microneedle array,” “interstitial fluid,” “progesterone,” “continuous monitoring,” “biosensor,” “immunoassay”)
Share any one of those details and I’ll help you narrow to the most relevant patent(s) and what they claim.
Sources
- DrugPatentWatch.com